| Year |
Citation |
Score |
| 2014 |
Celli JP, Rizvi I, Blanden AR, Massodi I, Glidden MD, Pogue BW, Hasan T. An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models. Scientific Reports. 4: 3751. PMID 24435043 DOI: 10.1038/srep03751 |
0.84 |
|
| 2013 |
Celli JP, Petrovic L, Massodi I, Rizvi I, Hasan T. Overcoming therapeutic resistance in pancreatic cancer is not a simple mix of PDT and chemotherapy: Evaluation of PDT-chemotherapy combinations in 3D tumor models Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8568. DOI: 10.1117/12.2010730 |
0.84 |
|
| 2013 |
Mensah LB, Mallidi S, Massodi I, Anbil S, Mai Z, Hasan T. Environmental effects on molecular biomarkers expression in pancreatic and brain cancer Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8568. DOI: 10.1117/12.2010697 |
0.84 |
|
| 2013 |
Rizvi I, Anbil S, Celli JP, Alagic N, Massodi I, Hasan T. Modeling stromal determinants of 3D tumor growth to inform PDT-mediated combination treatments Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8568. DOI: 10.1117/12.2010678 |
0.84 |
|
| 2012 |
Glidden MD, Celli JP, Massodi I, Rizvi I, Pogue BW, Hasan T. Image-Based Quantification of Benzoporphyrin Derivative Uptake, Localization, and Photobleaching in 3D Tumor Models, for Optimization of PDT Parameters. Theranostics. 2: 827-39. PMID 23082096 DOI: 10.7150/thno.4334 |
0.84 |
|
| 2012 |
Glidden MD, Massodi I, Rizvi I, Celli JP, Hasan T. Probing tumor-stroma interactions and response to photodynamic therapy in a 3D pancreatic cancer-fibroblast co-culture model Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8210. DOI: 10.1117/12.910924 |
0.84 |
|
| 2010 |
Massodi I, Moktan S, Rawat A, Bidwell GL, Raucher D. Inhibition of ovarian cancer cell proliferation by a cell cycle inhibitory peptide fused to a thermally responsive polypeptide carrier. International Journal of Cancer. 126: 533-44. PMID 19588502 DOI: 10.1002/ijc.24725 |
0.84 |
|
| 2009 |
Raucher D, Moktan S, Massodi I, Bidwell GL. Therapeutic peptides for cancer therapy. Part II - cell cycle inhibitory peptides and apoptosis-inducing peptides. Expert Opinion On Drug Delivery. 6: 1049-64. PMID 19743895 DOI: 10.1517/17425240903158909 |
0.84 |
|
| 2009 |
Massodi I, Thomas E, Raucher D. Application of thermally responsive elastin-like polypeptide fused to a lactoferrin-derived peptide for treatment of pancreatic cancer. Molecules (Basel, Switzerland). 14: 1999-2015. PMID 19513001 DOI: 10.3390/molecules14061999 |
0.84 |
|
| 2009 |
Massodi I, Bidwell GL, Davis A, Tausend A, Credit K, Flessner M, Raucher D. Inhibition of ovarian cancer cell metastasis by a fusion polypeptide Tat-ELP. Clinical & Experimental Metastasis. 26: 251-60. PMID 19169893 DOI: 10.1007/s10585-009-9237-z |
0.84 |
|
| 2008 |
Raucher D, Massodi I, Bidwell GL. Thermally targeted delivery of chemotherapeutics and anti-cancer peptides by elastin-like polypeptide. Expert Opinion On Drug Delivery. 5: 353-69. PMID 18318656 DOI: 10.1517/17425247.5.3.353 |
0.84 |
|
| 2007 |
Massodi I, Raucher D. A thermally responsive Tat-elastin-like polypeptide fusion protein induces membrane leakage, apoptosis, and cell death in human breast cancer cells. Journal of Drug Targeting. 15: 611-22. PMID 17968715 DOI: 10.1080/10611860701502780 |
0.84 |
|
| 2005 |
Massodi I, Bidwell GL, Raucher D. Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 108: 396-408. PMID 16157413 DOI: 10.1016/j.jconrel.2005.08.007 |
0.84 |
|
| Show low-probability matches. |